marco a. loza-mejĂa
Universidad La Salle
Mexico City, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Universidad La Salle
Mexico City, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Shanghai Cancer Institute
Shanghai, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Araraquara
Araraquara, Brazil
Review Editor
Anti-Infective Agents
Faculty of Chemistry, University of the Republic
Montevideo, Uruguay
Review Editor
Anti-Infective Agents
Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas
Quito, Ecuador
Review Editor
Anti-inflammatory and Immunomodulating Agents
National Autonomous University of Mexico
México City, Mexico
Review Editor
Anti-Cancer Drugs
University of TĂĽbingen
TĂĽbingen, Germany
Review Editor
Technologies and Strategies to Enable Drug Discovery
University of Nangui Abrogoua
Abidjan, CĂ´te d'Ivoire
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Technologies and Strategies to Enable Drug Discovery
University of California, Santa Barbara
Santa Barbara, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Universiti Malaysia Sabah
Kota Kinabalu, Malaysia
Review Editor
Anti-Cancer Drugs
University of Lisbon
Lisbon, Portugal
Review Editor
Anti-Cancer Drugs
TMC Clinical Development Consulting, Inc
Durham, United States
Review Editor
Dermatologic Drugs
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Anti-inflammatory and Immunomodulating Agents
GlycoMimetics, Inc.
Rockville, Maryland, United States
Review Editor
Dermatologic Drugs
Departamento de Quimica Organica, Laboratorio de Quimica Farmaceutica, Facultad de Quimica, Universiodad de la Republica, Uruguay
Montevideo, Uruguay
Review Editor
Anti-Infective Agents